Yes the complete lack of experience in anything MM related or even biology/horticulture related from the Medcan directors is much more of an alarm. As other posters have stated, it’s basically like they set this company up to sell it to someone desperate enough to buy the licenses, but why couldn’t AK get the licenses himself? And why are we paying AK 45% of the entire company when he can’t even produce the main thing QBL wanted out of him, a MM license? I’ve said it before and I’ll say it again, the MCL deal is an absolute shocker, if it wasn’t so expensive and was fair to QBL concisering they are the only reason MCL has gotten to where it is today through their cash and management, then I’m sure the market would of taken this thing a whole lot better.
- Forums
- ASX - By Stock
- Qbl looking a lot more healthy, updates are meant to be out this week
Yes the complete lack of experience in anything MM related or...
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online